A tri-marker proliferation index predicts biochemical recurrence after surgery for prostate cancer.
Prostate cancer exhibits tremendous variability in clinical behavior, ranging from indolent to lethal disease. Better prognostic markers are needed to stratify patients for appropriately aggressive therapy. By expression profiling, we can identify a proliferation signature variably expressed in pros...
Main Authors: | Sameer Malhotra, Jacques Lapointe, Keyan Salari, John P Higgins, Michelle Ferrari, Kelli Montgomery, Matt van de Rijn, James D Brooks, Jonathan R Pollack |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3100337?pdf=render |
Similar Items
-
UDP-glucuronosyltransferases and biochemical recurrence in prostate cancer progression
by: Delores J. Grant, et al.
Published: (2017-07-01) -
Racial Disparities in Prostate Cancer Incidence, Biochemical Recurrence, and Mortality
by: Cathryn H. Bock, et al.
Published: (2011-01-01) -
Early stage prostate cancer: biochemical recurrence after treatment
by: Danielle A. Zanatta, et al.
Published: (2014-04-01) -
NEW BIOCHEMICAL MARKERS OF RECURRENCE OF PROSTATE CANCER AFTER HIS TREATMENT
by: M. B. Chibichyan, et al.
Published: (2013-09-01) -
Advanced Imaging of Biochemical Recurrent Prostate Cancer With PET, MRI, and Radiomics
by: Faiq Shaikh, et al.
Published: (2020-08-01)